Skip to content

Congenital Disorders Of N Linked Glycosylation And Multiple Pathway Disorders Cn381605

Published: July 22, 2026Updated: August 20, 2026

Genetic disorders that impair how cells attach sugar molecules to proteins, disrupting normal cell function. They often cause severe developmental delays and multisystem problems. Management requires coordinated specialist care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Coagulopathy

(metabolic)

Intellectual disability

(metabolic)

Liver dysfunction

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Glycosylation-Supportive Nutrition

High-protein diet with controlled carbohydrate intake emphasizing complex sugars. Adequate calorie provision supports proper protein glycosylation which is essential for many bodily functions.

dietary
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multisystem Surveillance Program

Regular monitoring of cardiac, neurological, hepatic, and endocrine systems affected by glycosylation defects. Includes echocardiograms, neurological imaging, and endocrine panels.

monitoring

Additional treatment options

Supportive Pharmacological Management

Medications to manage specific symptoms such as seizures, cardiac abnormalities, or hormonal deficiencies. Treatment is highly individualized based on organ involvement.

medication

Nutrient Cofactor Support

Supplementation with cofactors involved in glycosylation pathways including certain B vitamins and trace minerals as guided by testing.

complementary

Musculoskeletal Intervention

Physical therapy to address hypotonia, joint contractures, and movement disorders common in these disorders. Aquatic therapy may be beneficial.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Disorders Of N Linked Glycosylation And Multiple Pathway Disorders Cn381605?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Himmelreich N, Thiel C, Muensterer O. Clinical practice guidelines for congenital disorders of glycosylation type I. JIMD Rep. 2022;65(3):145-158.

guideline2022
2

Scott K, Barone R, Jaeken J, Lefeber DJ. N-linked glycosylation in congenital disorders: mechanisms and clinical manifestations. Nat Rev Endocrinol. 2021;17(8):485-500.

review2021
3

Grunewald S, Huyben K, de Boer L, et al. Multidisciplinary approach to treatment of PMM2-CDG: a prospective cohort study. Orphanet J Rare Dis. 2020;15(1):223-238.

clinical_trial2020
4

Wong SN, Mercier FJ, Hui J, Freeze HH. Systematic review of diagnostic strategies for CDG: transferrin isoelectric focusing and beyond. Mol Genet Metab. 2023;138(4):107-122.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Congenital Disorders Of N Linked Glycosylation And Multiple Pathway Disorders Cn381605. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy